Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Post by FelixFunon Nov 15, 2018 7:08pm
145 Views
Post# 28983634

Emerald Health Pharma Phase I trial is currently underway

Emerald Health Pharma Phase I trial is currently underwayEmerald Health Pharma Phase I trial is currently underway in Australia. This is the first cannabidiol derivative in clinical development affecting known targets involved in and . Dr. Jim DeMesa spoke with Neurology Live: [url=https://bit.ly/2Fqy8TV ][/url].

User image

<< Previous
Bullboard Posts
Next >>